반응형
Global Data Intelligence Center
구분 보고서 (영문) 업로드일
제약·바이오
& 임상시험
Bio/Pharmaceutical Outsourcing Report, December 2022 12-19-2022
Emerging Market Outsourcing Report Q4 2022 12-15-2022
December Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing Q4 2022 12-20-2022
Bispecific Antibodies to Threaten Multiple Myeloma Cell Therapy in the US in 2023 12-20-2022
질환별 B-Cell Non-Hodgkin's Lymphoma: Cell Therapy 15-Market Assessment and Forecast 12-28-2022
Colorectal Cancer: Cell & Gene Therapies Market Assessment and Forecast 12-22-2022

반응형
반응형
Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약·바이오
& 임상시험
Emerging Market Outsourcing Report Q4 2022 12-15-2022
Clinical Trials: The Expanding Landscape of Regenerative Medicine 11-30-2022
High Hopes for mRNA Anti-Cancer Vaccines, with Moderna and Merck Touting Success 12-15-2022
Pulmonary Arterial Hypertension: Seven-Market Drug Forecast and Market Analysis Update 12-12-2022
질환별 Congenital Fibrinogen Deficiency: Opportunity Assessment and Forecast 12-09-2022
Bile Duct Cancer (Cholangiocarcinoma): Competitive Landscape 11-30-2022

반응형
반응형
Global Data Intelligence Center 
구분 보고서 (영문) 업로드 날짜
제약/바이오/
임상시험
Slow Progress for Female Contraceptive Trials 08-30-2023
Samsung Bioepis and Organon’s SB5 Displays Promise in Humira Biosimilar Study 08-31-2023
Eli Lilly Gearing Up to Infiltrate the Anti-Obesity Market as Phase III Trial for Retatrutide Begins 08-31-2023
Contract Manufacturing: Opportunities and Threats – August 2023 08-31-2023
Depression Clinical Trials During and After the COVID-19 Pandemic 08-31-2023
Highly anticipated first 10 drugs released for Medicare price negotiation could see minimal commercial impact 09-01-2023
Exelixis’s Cabometyx Phase III Trial Results Spark Hope for Patients with Pancreatic NETs 09-01-2023
질환별 IgA Nephropathy (Berger's Disease): Competitive Landscape 08-29-2023
Record Number of Respiratory Syncytial Virus (RSV) Designations Awarded in 2022 08-30-2023
Idiopathic Hypersomnia: Competitive Landscape 08-31-2023
A Market Leader Shuffle Is Expected in the Crohn’s Disease Space 08-31-2023
Diabetic Nephropathy: Competitive Landscape 09-01-2023
Leading Players in Decompensated Cirrhosis Due to NASH 09-05-2023
Oral Contraceptive Pills Found to Increase the Risk of Mood Disorders in Women 09-05-2023
Major Unmet Needs Plague Classification and Treatment of Myasthenia Gravis Patients 09-06-2023
컨퍼런스/심포지엄/학회 VTE Risk Elevated in Swedish Patients Hospitalized for COVID-19 09-05-2023
Direct Oral Anticoagulants’ Positive Effects on Cancer-Associated VTE 09-05-2023
Myosin Inhibitors’ Central Role in the Future of Hypertrophic Cardiomyopathy 09-05-2023
New 2023 Guidelines for the Management of Cardiomyopathies 09-05-2023

반응형
반응형
Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/임상시험 Positive Results from Rybrevant Trial Solidify Janssen’s Foothold in EGFR-Mutated NSCLC 09-08-2023
CureVac Highlights Shift in Seasonal Influenza Vaccines Development Pipeline 09-14-2023
Novo Nordisk’s Wegovy to Start Being Supplied by NHS in England 09-15-2023
Market Cap Rebound by Top 20 Biopharmaceutical Companies in Q2 2023 09-15-2023
Forxiga Flunks Primary Endpoint in DICTATE-AHF Trial 09-21-2023
Alvotech’s AVT05 in Phase III Rheumatoid Arthritis Study, as the Sole Candidate 09-21-2023
GSK’s Ojjaara Receives FDA Approval for Treating Myelofibrosis Patients with Anemia 09-21-2023
Clinical Trials Feasibility, Risk Assessment and Planning for Success – A Case Study 09-22-2023
질환별 Influence of Social Class on AIDS Incidence and Mortality in Brazil 09-12-2023
Heart Failure: Epidemiology Forecast to 2032 09-19-2023
Sepsis: 68-Market Analysis and Sales Forecast 09-21-2023
Can Steatosis-Associated Fibrosis Estimator Scores Improve Diagnosis of Nonalcoholic Fatty Liver Disease? 09-21-2023
New Evidence Shows Depression as a Major Risk for Type 2 Diabetes 09-22-2023
High Global Prevalence of HPV in Sexually Active Men 09-22-2023
The Burden of Hepatitis B and Hepatitis C-Related Illnesses 09-22-2023
컨퍼런스/심포지엄/학회 Disparity in the Distance Between Disease Prevalent Populations and Trial Locations 09-14-2023
Could Gilead's Trodelvy Be the Next TROP-2 Therapy Game-Changer in NSCLC Treatment 09-22-2023
반응형

+ Recent posts